Skip to main content

Table 4 Multivariable-adjusted associations of CAA diagnosis with the number and severity of NPS.

From: Neuropsychiatric symptoms and lifelong mental activities in cerebral amyloid angiopathy – a cross-sectional study

 

Number of NPS

NPS total severity

Incidence rate ratio (95% CI)

p-value

Estimate (95% CI)

p-value

Step 1

CAA diagnosis

Age

Female

Years of education

6.07 (3.15 to 11.69)

1.05 (1.01 to 1.09)

1.31 (0.76 to 2.26)

0.98 (0.89 to 1.08)

< 0.001

0.009

0.324

0.738

3.32 (1.86 to 4.79)

0.10 (0.02 to 0.18)

0.56 (-0.64 to 1.78)

-0.01 (-0.22 to 0.19)

< 0.001

0.015

0.355

0.913

Step 2

CAA diagnosis

Age

Female

Years of education

Arterial hypertension

6.03 (2.99 to 12.19)

1.05 (1.01 to 1.09)

1.31 (0.76 to 2.26)

0.98 (0.89 to 1.08)

1.01 (0.47 to 2.18)

< 0.001

0.009

0.323

0.743

0.964

3.36 (1.78 to 4.94)

0.10 (0.02 to 0.18)

0.56 (-0.66 to 1.78)

-0.01 (-0.22 to 0.19)

-0.11 (-1.83 to 1.61)

< 0.001

0.016

0.366

0.902

0.898

Step 3

CAA diagnosis

Age

Female

Years of education

Arterial hypertension

AD pathology

4.43 (1.97 to 9.94)

1.05 (1.01 to 1.09)

1.28 (0.74 to 2.20)

0.98 (0.89 to 1.07)

1.09 (0.51 to 2.34)

1.15 (0.50 to 2.64)

< 0.001

0.009

0.366

0.720

0.816

0.726

3.34 (1.75 to 4.92)

0.09 (0.01 to 0.18)

0.57 (-0.65 to 1.80)

-0.01 (-0.22 to 0.19)

-0.06 (-1.79 to 1.66)

0.74 (-1.13 to 2.62)

< 0.001

0.025

0.355

0.883

0.944

0.433

Step 4

CAA diagnosis

Age

Female

Years of education

Arterial hypertension

AD pathology

4.86 (2.20 to 10.73)

1.05 (1.01 to 1.08)

1.26 (0.74 to 2.13)

0.98 (0.89 to 1.07)

1.08 (0.52 to 2.26)

1.50 (0.62 to 3.57)

< 0.001

0.009

0.380

0.746

0.823

0.360

3.56 (1.94 to 5.19)

0.09 (0.00 to 0.18)

0.58 (-0.65 to 1.82)

0.00 (-0.22 to 0.21)

-0.08 (-1.81 to 1.65)

1.10 (-0.92 to 3.13)

< 0.001

0.031

0.349

0.972

0.927

0.281

APOE status

Ho/he APOEε4

Ho/he APOEε2

APOEε4 and APOEε2

0.48 (0.26 to 0.90)

0.51 (0.22 to 1.22)

1.52 (0.36 to 6.30)

0.022

0.135

0.562

-0.90 (-2.45 to 0.63)

-1.01 (-3.17 to 1.13)

0.41 (-3.01 to 3.85)

0.247

0.350

0.809

  1. Note: CI: confidence interval. AD: Alzheimer’s disease. Ho/he: homozygote or heterozygote. Significant p-values are marked bold